FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:50-51 January 4, 1996 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Cancer of the ovarian epithelium is the fourth most common cause of death from cancer in women and the leading cause of death from gynecologic cancer. At the time of diagnosis, the majority of women with the disease have involvement of one or both ovaries, with peritoneal implants outside the pelvis or positive retroperitoneal–inguinal nodes (stage III, according to the classification of the International Federation of Gynaecology and Obstetrics), or they have distant metastases (stage IV).¹

Surgery and chemotherapy are the cornerstones of therapy for advanced ovarian cancer. Before chemotherapy is initiated, a maximal effort should be made to remove . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Lavarino, C., Pilotti, S., Oggionni, M., Gatti, L., Perego, P., Bresciani, G., Pierotti, M. A., Scambia, G., Ferrandina, G., Fagotti, A., Mangioni, C., Lucchini, V., Vecchione, F., Bolis, G., Scarfone, G., Zunino, F. (2000). p53 Gene Status and Response to Platinum/Paclitaxel-Based Chemotherapy in Advanced Ovarian Carcinoma. JCO 18: 3936-3945 [Abstract] [Full Text]  
• Neijt, J. P., Engelholm, S. A., Tuxen, M. K., Sorensen, P. G., Hansen, M., Sessa, C., de Swart, C. A. M., Hirsch, F. R., Lund, B., van Houwelingen, H. C. (2000). Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian Cancer. JCO 18: 3084-3092 [Abstract] [Full Text]  
• Travis, L. B., Holowaty, E. J., Bergfeldt, K., Lynch, C. F., Kohler, B. A., Wiklund, T., Curtis, R. E., Hall, P., Andersson, M., Pukkala, E., Sturgeon, J., Stovall, M., Storm, H., Clarke, E. A., Boice, J. D., Gospodarowicz, M. (1999). Risk of Leukemia after Platinum-Based Chemotherapy for Ovarian Cancer. NEJM 340: 351-357 [Abstract] [Full Text]  
• (1996). PACLITAXEL PLUS CISPLATIN FOR OVARIAN CANCER. JWatch General 1996: 1-1 [Full Text]